On March 6, 2026, GSK plc purchased 690,000 of its own shares at prices ranging from 2,029p to 2,080p per share, part of an ongoing buyback program, totaling 7,156,000 shares bought since February 17, 2026. The company now holds 247,047,094 shares in treasury out of 4,069,121,728 total shares issued.